PDCD1 and melanoma: Once tolerance is destroyed by PD-1/PD-L1 blockade, these T cells will be activated by melanoma or by melanocytes, thus attacking melanoma cells as well as normal melanocytes, which may account for the relevance between the efficacy and irAEs of ICIs.